Most mid-size companies are now under pressure to do something with AI. The pressure comes from boards, customers, competitors, and internal teams who are using AI tools in their personal lives and asking why the company is not. The question is rarely whether to start. It is how to start without wasting a year on the wrong thing.

For a company at this stage, the practical answer is to run a structured readiness step before committing to a project. Here is what that actually involves and why it changes the odds of success.

What readiness actually means in practice

Readiness for AI is not the same as readiness for a software project. A traditional software project needs a problem, a budget, and a team. An AI project needs all of those plus three other things. It needs data that is accessible, complete and consistent. It needs business processes that are stable enough that a model can be trained on them without becoming obsolete in six months. And it needs an organisation that will trust and adopt the output of a model rather than overriding it on intuition.

When mid-size companies skip the readiness step, the failure mode is predictable. The team starts building. The data turns out to be more fragmented than expected. The process being modelled turns out to be changing as the project progresses. The model gets built, technically works, and then sits unused because nobody trusts the output. None of these failures are technical. They are organisational, and they could have been spotted in a readiness audit.

The data audit step

The first piece of a readiness assessment is an honest audit of the data that the candidate AI project would depend on. Where does it live. Who owns it. What state is it in. Is it complete enough and consistent enough that a model could be trained on it. Is there enough history to be useful. Is the labelling reliable, or would the project need a labelling phase before any model work could start.

A proper AI readiness assessment usually surfaces the data work that is needed before the project can start, and that is one of the most useful things it produces. Companies that go in expecting a green light and instead get a clear list of data fixes to address first usually save themselves six to twelve months of pain. The list itself is more valuable than the green light would have been.

The audit also flags data that exists but is locked behind systems that do not currently support extraction. Legacy systems often store useful data in formats that cannot be queried at scale. Knowing that early changes the project plan in important ways.

The process audit step

The second piece is the process audit. Even with good data, an AI project needs a process that is stable enough to model and important enough that improving it is worth the effort. Processes that are still being designed are not good candidates for a first AI project. Processes that are deeply embedded but unimportant to the business are also not good candidates.

The right candidate is a process that is well established, generates meaningful business value, has measurable outputs, and where small improvements in accuracy or speed compound into significant value over time. Customer support triage, document processing, demand forecasting, fraud detection, and lead scoring tend to fit these criteria. New product design, novel customer interactions, and fast-changing operational workflows usually do not, at least for a first project.

According to research summarised by McKinsey on the state of AI in enterprise, the gap between organisations that have captured meaningful value from AI and those that have not is largely explained by whether the work was concentrated on a small number of high-value workflows rather than spread thinly across many opportunities.

The data governance question

Closely linked to the data audit is the question of data governance. For an AI project to be sustainable, the underlying data needs to be governed in a way that supports ongoing model use. That means clear ownership, defined quality standards, documented lineage, and a process for handling changes to source systems. Without these, the model will degrade as the data feeding it drifts. A meaningful AI data management approach is part of every successful AI programme, not an add-on after the model is live. Companies that treat data governance as a follow-up project often spend the second year of their AI work rebuilding what the first year should have established.

The shortlist of candidate projects

A useful readiness assessment ends with a shortlist of two or three candidate first projects, with each one analysed for data readiness, process fit, business value, and organisational fit. The shortlist is what the leadership team uses to decide where to start.

The best first project is rarely the most ambitious one on the list. It is usually the one with the cleanest data, the most stable process, a clearly defined success metric, and an internal sponsor who will actively use the output. The ambitious projects come second, after the first has demonstrated that the company can deliver an AI project end to end.

For most mid-size companies the second project is the one where the value really starts to compound. The first project pays for itself in modest ways. The second and third projects, built on the platform and the team developed during the first, are where the transformation begins to be visible.

What this means for the next quarter

For a mid-size company that has not yet started, the right move is rarely to commission a strategy. The right move is to scope a focused readiness assessment that produces a shortlist of viable first projects within four to eight weeks. The output is a clear go-no-go on the data, the processes, and the candidate projects.

From there, the company can move quickly into a defined first project with a realistic chance of reaching production within six to nine months. That sequence is what separates the companies that have something running by the end of the year from those who are still circling the topic.

Treatment for bipolar disorder has expanded substantially over the last decade. Mood stabilisers remain the foundation, but several other options have entered routine clinical practice, including ketamine-based treatments for specific situations. For patients and families trying to make sense of the options, it can be hard to know where any single treatment actually fits.

Here is the practical framework for understanding bipolar treatment in 2026, what the role of ketamine actually is, and how a well-run treatment plan combines several approaches.

How bipolar treatment is actually structured

A standard treatment plan for bipolar disorder is built in layers. The foundation is a mood stabiliser, which is the class of medication that reduces the frequency and severity of mood episodes over time. The specific stabiliser depends on the patient subtype, prior treatment history, side effect tolerance, and other clinical factors.

On top of the foundation, additional treatments are added as needed. These can include atypical antipsychotics for certain presentations, antidepressants used cautiously in specific situations, and adjunctive treatments for symptoms like sleep disturbance or anxiety. The combination is typically adjusted over time as the patient stabilises and the clinical picture becomes clearer.

Therapy is a meaningful part of the plan in almost all serious bipolar treatment. The therapies with the strongest evidence include cognitive behavioural therapy adapted for bipolar disorder, interpersonal and social rhythm therapy, and family-focused therapy. The work focuses on managing mood episodes, identifying early warning signs, stabilising daily routines, and improving relationships that are often strained by the condition. A serious bipolar disorder treatment NYC plan integrates medication and therapy from the start rather than treating them as separate workstreams.

Where ketamine treatment fits in

Ketamine-based treatments have become an important option for a specific scenario in bipolar disorder. The scenario is bipolar depression that has not responded adequately to standard treatments and that is causing significant impairment. In this situation, ketamine therapy offers a treatment with a different mechanism of action than standard antidepressants and a different timeline of effect, often producing visible response within days rather than weeks.

The clinical decision to add ketamine to a bipolar treatment plan is not casual. It requires careful evaluation of the patient mood pattern, the current phase of illness, the existing medication regimen, and the risk profile. Used appropriately, ketamine for bipolar NYC can produce rapid response in patients who have been depressed for an extended period and who have not responded to other approaches. Used carelessly, it can destabilise the patient and contribute to a switch into an elevated mood state.

This is why ketamine treatment for bipolar disorder should be delivered in a clinic with experience treating bipolar patients specifically, rather than depression alone. The clinical judgement that distinguishes a good candidate from a poor one is built up over many bipolar cases and is not transferable from straightforward unipolar depression treatment.

The risks that need to be managed

The most important risk in adding any antidepressant treatment to a bipolar regimen is the possibility of triggering a switch from depression into an elevated mood state. The risk is well documented for standard antidepressants used without a mood stabiliser. It is less well characterised for ketamine specifically, but the underlying concern applies.

In practice, this means that ketamine treatment in bipolar patients is typically delivered with a mood stabiliser already in place, with close monitoring through the course, and with clear protocols for what to do if early signs of mood elevation emerge. A clinic that proposes ketamine treatment for a bipolar patient without addressing this risk explicitly is not operating to the standard of care.

According to information from the National Institute of Mental Health on bipolar disorder, treatment of bipolar depression requires careful selection of agents and close monitoring to balance the benefit of treating the depressive phase against the risk of destabilising mood, with newer treatments evaluated in this context rather than considered in isolation.

What good monitoring looks like through treatment

Bipolar treatment that goes well is built on consistent monitoring. The patient typically tracks daily mood and sleep using a structured rating tool. The clinician reviews the pattern at each appointment and adjusts the treatment plan based on what the data shows rather than relying on the patient recall of how they felt over the previous weeks. This is more important in bipolar disorder than in many other conditions because patterns over time matter more than any single moment.

When ketamine or other rapid-acting treatments are added to the plan, the monitoring becomes more frequent in the period around the treatment course. Sleep is watched particularly carefully, since changes in sleep are often the earliest sign of a shift in mood state. Family members or partners may be enlisted to help with monitoring when the patient is in the middle of a depressive phase that limits their own ability to notice changes accurately.

For patients in long-term bipolar treatment, the monitoring becomes a normal part of life. The investment of attention is what allows the treatment to be adjusted before small changes become full episodes.

The role of lifestyle stabilisation

Three lifestyle elements have a measurable effect on bipolar mood stability. The first is sleep. Disrupted sleep is one of the most reliable triggers of mood episodes in either direction. Maintaining a consistent sleep schedule, including weekends, is one of the most useful interventions a patient can make. The second is alcohol and substance use. Both interfere with mood stability and with medication effectiveness, and reducing or eliminating them is part of most treatment plans. The third is structured routines for daily activity, eating, and exercise. The structure itself, regardless of the specific content, contributes to mood stability over time.

None of these replace medication. All of them make medication work better and reduce the frequency of episodes that require additional treatment. A treatment plan that addresses lifestyle explicitly tends to be more durable than one that focuses only on the medication regimen.

When to seek a specialist evaluation

For patients whose bipolar disorder is well controlled on a standard regimen, the primary care or general psychiatry team can usually manage the ongoing care. For patients whose presentation has been more difficult to manage, including those with frequent episodes, partial response to multiple medications, or treatment-resistant depressive phases, a specialist evaluation can change the plan substantially.

A specialist who works regularly with treatment-resistant bipolar presentations has access to treatments and combinations that are less commonly used in general practice, including ketamine, certain newer mood stabilisers, and structured combination approaches. Patients who have been treated for years without adequate stability often see a meaningful improvement in the first six to twelve months of specialist care, simply because the treatment plan is constructed with more tools and more experience than was previously available to them.

The right time to seek that evaluation is not when the patient is in crisis, but when the existing plan has stopped producing the level of stability the patient and family expected. A planned referral produces better outcomes than a crisis referral, and the work of finding the right specialist is best done during a stable period.

The world of government contracting often feels like a giant mechanism made of gears, spreadsheets, and endless acronyms. When people talk about massive programs like TRICARE or Medicaid, the conversation usually shifts immediately toward budget cycles, compliance hurdles, and technical specifications. It is easy to get lost in the sea of red tape and forget that at the very end of every single contract, there is a person waiting for care. Whether it is a veteran looking for mental health support or a family relying on state based insurance, the stakes are deeply personal.

Lately, there has been a lot of chatter about the rapid push for efficiency in these public programs. We are seeing a major trend this week where agencies are prioritizing speed and automation more than ever before. While moving faster is generally a good thing, there is a growing concern that we might be automating the empathy right out of the system. Efficiency is a great tool, but it should never be the ultimate goal. The goal is, and always should be, better outcomes for the people who rely on these services.

Bridging the Gap Between Policy and People

When you look at how these massive systems operate, there is often a disconnect between the people writing the policies and the people executing them on the ground. This is where the real problem solving happens. It is not just about following the rules; it is about understanding the spirit of the mission. Joanne M. Frederick, CEO of Government Market Strategies (GMS), has spent over 35 years navigating this exact tension. In a field that can often feel cold and bureaucratic, she has championed the idea that strategic clarity must be paired with an innovative mindset that keeps the human impact front and center.

Working within the framework of programs like the Veterans Health Administration or Medicare requires a specific kind of patience. You are dealing with layers of history and complex regulatory environments that would make most heads spin. But if you approach these challenges as just another series of boxes to check, you miss the opportunity to actually innovate. True innovation in this space is about finding ways to make the system work for the individual, not just the agency. It is about aligning performance with a sense of purpose.

The Future of Public Trust

As we move further into a year where technology is moving faster than our ability to regulate it, the government sector faces a bit of an identity crisis. How do we stay modern without losing the trust of the public? There is a delicate balance between being a high performing organization and being a trustworthy partner to the community.

We see this tension in local issues as well, such as the ongoing debates about protecting conserved land and farms. It is a reminder that people want to feel protected by their institutions, not overlooked by them. This is likely why leaders in this space often find themselves involved in nonprofit work or community advocacy outside of their day jobs. It all stems from the same root: a desire to see resources used wisely and fairly.

The companies that will succeed in the coming years aren't necessarily the ones with the loudest marketing or the biggest budgets. They will be the ones that can prove they understand the weight of the responsibility they are taking on. Government contracting isn't just a business transaction; it is a public trust. When a firm helps secure a contract for health services, they are essentially promising the government and the citizens that they will take care of a piece of the social fabric.

Moving Beyond the Status Quo

To really move the needle in government healthcare, we have to stop settling for good enough. The status quo in many of these programs is a product of decades of incremental changes, which often results in a fragmented experience for the patient. Solving these problems requires more than just technical skill; it requires a holistic view of health. It is interesting to see how leadership in this industry is starting to blend traditional business acumen with a deeper focus on transformative change.

If we want the next generation of government programs to be better than the last, we have to start asking different questions. Instead of asking how we can save five percent on a contract, we should be asking how we can ensure a veteran doesn't have to drive three hours for an appointment. Instead of focusing solely on the bottom line, we should be looking at how we can align corporate performance with the actual health objectives of the public.

At the end of the day, the work being done by organizations like GMS is about more than just navigating the federal landscape. It is about ensuring that the massive machinery of the state actually serves the people it was built to protect. It takes a certain kind of leader to see through the paperwork and stay focused on the mission, but that is exactly what the future of this industry requires. We need more than just contractors; we need stewards of the public good.